BIOSGN.ST(BIOSGN.ST)
BIOSGN.ST
No analyst ratings available
No analyst price targets available for BIOSGN.ST
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1M | $259M |
| Low | $1M | $259M |
| High | $1M | $259M |
| EBITDA Avg | $840,000 | $155M |
| Low | $840,000 | $155M |
| High | $840,000 | $155M |
| EBIT Avg | $840,000 | $155M |
| Low | $840,000 | $155M |
| High | $840,000 | $155M |
| Net Income Avg | $-23M | $235M |
| Low | $-23M | $235M |
| High | $-23M | $235M |
| EPS Avg | $-10.00 | $100.00 |
| Low | $-10.00 | $100.00 |
| High | $-10.00 | $100.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |